MedPath

Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid

Not Applicable
Completed
Conditions
Pharmacological Action
Interventions
Procedure: Zinc phosphate cement placement
Procedure: Amalgam placement
Procedure: Tetric EvoCeram placement
Procedure: Beautifil placement
Procedure: Zinc polycarboxylate cement placement
Procedure: Glass ionomer cement placement
Registration Number
NCT03522532
Lead Sponsor
Ervin Taso
Brief Summary

The goal of the study was to ascertain the influence of dental caries and teeth position as well as the type and amount of the applied dental materials (DMs) on the oxidative stress (OS) status in gingival crevicular fluid (GCF).

Detailed Description

Six DMs were tested by investigators, each sealed in one session: amalgam (Amg), zinc phosphate cement (ZnPhC), zinc polycarboxylate cement (ZnPoC), glass ionomer cement (GIC) and composites, Tetric EvoCeram (TEC) and Beautifil (BF).

The study included 88 dental outpatients. Oxidative stress parameters, including malondialdehyde (MDA), glutathione (GSH) and total superoxide dismutase (tSOD) activity were measured in GCF, before (day 0) and after treatment (7th and 30th day).

Antagonistically positioned healthy teeth were used as a control.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria

Criteria related to the condition of teeth:

  • Presence of proximal caries on anterior and posterior teeth
  • Existence of the antagonistic tooth ("mirror"-positioned healthy tooth) to be used as control
  • An absence of fresh post-extraction or traumatic wounds in the restoration area or in the area of restored surfaces
  • An absence of infection in the area of restored surfaces

Other influencing criteria:

  • Absence of bone-associated diseases or treatments
  • Satisfactory oral hygiene
  • Patients exhibiting good compliance
Exclusion Criteria

Criteria related to the condition of teeth:

  • Endodontic and/or periodontal infections in the area of the cervical filling
  • Presence of periodontopathy
  • Prominent periodontal pockets
  • Subgingival carries
  • Prominent fillings outside the cavity

Other influencing criteria:

  • Patients on radiation or immunosuppressive therapy
  • Presence of bone-associated diseases and malignant diseases
  • Patients using drugs/alcohol/cigarettes (> 20 cigarettes per day)
  • Bad oral hygiene
  • Patients exhibiting poor compliance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Zinc phosphate cement (ZPhC)Zinc phosphate cement placementZinc phosphate cement was sealed in 7-K2 patients, 4-K3 patients, 1-K4 patients and 2-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Amalgam (Amg)Amalgam placementAmalgam was sealed in 8-K2 patients and 6-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Tetric EvoCeram (TEC)Tetric EvoCeram placementTetric EvoCeram was sealed in 12-K2 patients and 5-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Beautifil (BF)Beautifil placementBeautifil was sealed in 15-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Zinc polycarboxylate cement (ZPoC)Zinc polycarboxylate cement placementZinc polycarboxylate cement was sealed in 5-K2 patients, 4-K3 patients and 5-K4 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Glass ionomer cement (GIC)Glass ionomer cement placementGlass ionomer cement was sealed in 11-K2 patients, 2-K3 patients and 1-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Primary Outcome Measures
NameTimeMethod
Changes in the levels of MDA in dental patients GCF after the applied treatments0th, 7th and 30th days.

The concentration of MDA in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.

Secondary Outcome Measures
NameTimeMethod
Changes in the levels of GSH in dental patients GCF after the applied treatments0th, 7th and 30th days.

Concentration of GSH in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.

Trial Locations

Locations (1)

Military Medical Academy

🇷🇸

Belgrade, Serbia

© Copyright 2025. All Rights Reserved by MedPath